24H | Moderna and TotalEnergies Jump 8%; GitLab Drops 8%; Arbutus Biopharma Sinks 12%

Tiger Newspress
Mar 04

Moderna has agreed to pay Genevant Sciences, a subsidiary ​of Roivant Sciences, and Arbutus Biopharma up to $2.25 billion to settle ‌a long-running legal fight over the technology that made its COVID-19 vaccine possible, the companies said. Moderna shares jumped 7.5% in overnight trading, while Arbutus Biopharma dropped 12.4%.

TotalEnergies has agreed to divest a 50% stake in 11 battery storage projects in Germany, with a combined capacity ranging from 789MW to 1.63 gigawatt-hours (GWh), to Allianz Global Investors (AllianzGI). TotalEnergies shares gained 7.5% in overnight trading.

GitLab expects sales to slow this year and outlined several initiatives to help boost guidance that its chief executive officer described as disappointing. The shares sank 8% in overnight trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10